Clinical Trials Directory

Trials / Completed

CompletedNCT01722019

Prospective Multicentric Trial Between Radiofrequency Ablation With VNUS Closure Fast ® and Endovenous Ablation With 1470 nm Diode Laser and Tulip Fiber ® for Treatment of Primary Venous Insufficiency.

Prospective Multicentric Randomised Trial Between Radiofrequency Ablation With VNUS Closure Fast ® and Endovenous Ablation With 1470 nm Diod Laser and Tulip Fiber ® for Treatment of Primary Venous Insufficiency.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
280 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Endovenous ablation of the greater saphenous vein has nowadays the same outcome as open crossectomy and stripping. The two most performed techniques for endovenous ablation are the endovenous laser ablation and the radiofrequency ablation. According to the trial of Rasmussen, they are equivalent for occlusion but the lower laser wave lengths resulted in more pain and paresthesia. The newer wave length of 1470 nm showed lesser side effects in observational studies. The aim of this study is to compare radiofrequency ablation with the VNUS closure fast ® with laser ablation with a 1470 nm wave length in combination with a new fiber, the Tulip fiber ®. This fiber has the shape of a tulip at his tip which avoids point necroses of the vessel wall and on consequence results in lesser side effects from wall perforations such as pain, haematoma,…

Conditions

Interventions

TypeNameDescription
DEVICETulip fiberLaser ablation with a wavelength of 1470 nanometers will be performed, in combination with a new sort of fiber: the tulip tip fiber.
DEVICEVNUS closure fastRadiofrequent ablation will be performed in combination with the catheter 'VNUS closure fast'.

Timeline

Start date
2014-01-01
Primary completion
2022-08-31
Completion
2022-08-31
First posted
2012-11-06
Last updated
2022-12-29

Locations

3 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01722019. Inclusion in this directory is not an endorsement.